Physician profile
Ali Saad
NPI 1952697112
$2,880.36
in general payments reported to CMS, 2019-2025
9 companies · $34.00 in 2025
The $34.00 reported for 2025 was less than what a typical Allergy & Immunology provider received nationally (typical 2025 total: $1,138).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,561 · 2020: $61.03 · 2022: $17.94 · 2023: $120 · 2024: $86.91 · 2025: $34.00.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $195 · Food and Beverage: $45.55.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $195.27 |
| Food and Beverage | $45.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $2,560.57 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $97.28 | 2023 | Dupixent |
| Sanofi-Aventis U.S. LLC | $63.99 | 2024 | |
| Astrazeneca Pharmaceuticals Lp | $39.16 | 2020 | |
| Amgen INC. | $34.00 | 2025 | |
| Avanos Medical | $22.92 | 2024 | Generator |
| Glaxosmithkline, LLC. | $22.63 | 2023 | Nucala |
| Novartis Pharmaceuticals Corporation | $21.87 | 2020 | |
| Alk-Abello, INC | $17.94 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ali Saad listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.